Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Development and Characterization of a Gel Formulation Integrating Microencapsulated Nitrofurazone

Full text
Author(s):
Balcao, Victor M. [1, 2] ; Santos, Milca G. [1] ; Martins, Paloma R. [1] ; Chaud, Marco V. [1] ; de Oliveira Junior, Jose M. [1] ; Tubino, Matthieu [3] ; Vila, Marta M. D. C. [1]
Total Authors: 7
Affiliation:
[1] Univ Sorocaba, Lab Dev & Evaluat Bioact Subst, BR-18023000 Sorocaba, SP - Brazil
[2] Univ Minho, Ctr Biol Engn, Inst Biotechnol & Bioengn, P-4710057 Braga - Portugal
[3] Univ Estadual Campinas, Inst Chem, BR-13083970 Campinas, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: CURRENT PHARMACEUTICAL BIOTECHNOLOGY; v. 14, n. 12, p. 1036-1047, 2014.
Web of Science Citations: 3
Abstract

Nitrofurazone (NTZ) is usually employed in the topical treatment of infected wounds and lesions of both skin and mucosa. Microencapsulation is a process utilized in the incorporation of active ingredients within polymers aiming at, among other objectives, the prolonged release of pharmaceutical compounds and protection from atmospheric agents (viz. moisture, light, heat and/or oxidation). With the goal of utilizing the microparticles containing encapsulated NTZ in pharmaceutical formulations, one prepared microparticles containing NTZ via ionotropic gelation of sodium alginate. The microparticles were characterized via scanning electron microscopy analyses, Fourier transform infrared spectroscopy (FTIR) analyses, via determination of encapsulation efficiency, and via thermal analyses (both TGA and DSC). The final gel formulation was also characterized rheologically. The extrusion/solidification technique employed to obtain the calcium alginate microparticles with encapsulated NTZ was found to be adequate, and produced an NTZ encapsulation efficiency of ca. 97.8% +/- 1.1%. The calcium alginate microparticles thus obtained, with encapsulated NTZ, exhibited an oval shape and hydrodynamic diameters between 500 mu m and 800 mu m. From the thermal analyses performed, together with information from the infrared spectra, one may conclude that NTZ did not strongly bind to the polymer, which may be favorable for the release of the active ingredient. From the results obtained in the present research effort, one may conclude that the microparticles produced possess the potential to be utilized as carriers for NTZ in pharmaceutical formulations such as gels, ointments, and solutions. (AU)